However, because PPARγ appears to be a tumour-type and tumour stage-specific modulator that is regulated by the ERK cascade, the MEK inhibitor PD0325901 together with RSG inhibited the growth of the tumours much better than PD0325901 along (Figure 2), which offers a potential opportunity for combination chemotherapy against HCC. This evidence concerns the gene PPARG and neoplasm.